is expressed in glycoconjugates that range in evolutionary diversity from bacteria to man, there is little information as to how this novel sugar is synthesized. Accordingly, biosynthetic studies were initiated in trout testis, an organ rich in KDN, to determine how this sialic acid is formed. These studies have shown that the pathway consists of the following three sequential reactions: 1) Man ؉ ATP 3 Man-6-P ؉ ADP; 2) Man-6-P ؉ PEP 3 KDN-9-P ؉ Pi; 3) KDN-9-P 3 KDN ؉ Pi. Reaction 1, catalyzed by a hexokinase, is the 6-O-phosphorylation of mannose to form D-mannose 6-phosphate (Man-6-P). Reaction 2, catalyzed by KDN-9-phosphate (KDN-9-P) synthetase, condenses Man-6-P and phosphoenolpyruvate (PEP) to form KDN-9-P. Reaction 3, catalyzed by a phosphatase, is the dephosphorylation of KDN-9-P to yield free KDN. It is not known if a kinase specific for Man (Reaction 1) and a phosphatase specific for KDN-9-P (Reaction 3) may exist in tissues actively synthesizing KDN. In this study, the KDN-9-P synthetase, an enzyme that has not been previously described, was identified as at least one key enzyme that is specific for the KDN biosynthetic pathway. This enzyme was purified 50-fold from rainbow trout testis and characterized. The molecular weight of the enzyme was estimated to be about 80,000, and activity was maximum at neutral pH in the presence of Mn 2؉ . N-Acetylneuraminic acid 9-phosphate (Neu5Ac-9-P) synthetase, which catalyzes the condensation of N-acetyl-D-mannosamine 6-phosphate and phosphoenol-pyruvate to produce Neu5Ac-9-P, was co-purified with the KDN-9-P synthetase. Substrate competition experiments revealed, however, that syntheses of KDN-9-P and Neu5Ac-9-P were catalyzed by two separate synthetase activities. The significance of these studies takes on added importance with the recent discovery that the level of free KDN is elevated in human fetal cord but not matched adult red blood cells and (25), , and KDN residue-cleaving sialidases (29 -31), have been identified and partially characterized, and their similarity and dissimilarity to the metabolism of Neu5Acyl residues have been described. In marked contrast, nothing is known concerning how the KDN monosaccharide is synthesized. Two pathways are possible for synthesis of the KDN monomer. First, it could be formed directly from Neu5Ac by deacylation and deamination. Alternatively, it could arise by de novo synthesis via enzymes different from those required for synthesis of Neu5Ac. However, no evidence for the direct conversion of Neu5Ac to KDN has been obtained in any tissue homogenates examined to date. Thus, de novo synthesis by a separate pathway appears to be plausible by analogy with synthesis of other ulosonic acids. For example, 3-deoxy-D-arabino-heptulosonic acid 7-phosphate, a biosynthetic precursor of aromatic amino acids (32), 3-deoxy-D-manno-octulosonic acid, a constituent of bacterial lipopolysaccharides (33, 34) and Neu5Ac (35) are synthesized through a series of similar reactions involving a condensation of phosphoenolpyruvate (PEP) and the relevant sugar phosphates, either erythrose 4-phosphate for 3-deoxy-D-arabino-heptulosonic acid 7-phosphate, arabinose 5-phosphate for 3-deoxy-D-manno-octulosonic acid 8-phosphate, or N-acetylmannosamine 6-phosphate (ManNAc-6-P) for Neu5Ac 9-phosphate. Accordingly, the de novo biosynthesis of KDN is hypothesized to involve the condensation of PEP and mannose 6-phosphate (Man-6-P), giving rise to KDN 9-phosphate (KDN-9-P). Two additional reactions, the 6-O- § To whom correspondence should be addressed. Fax: 81-52-789-4128; E-mail: kitajima@agr.nagoya-u.ac.jp. 1 The abbreviations used are: KDN, 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid or deaminated neuraminic acid; KDN-9-P, KDN 9-phosphate; DMB, 1,2-diamino-4,5-methylenedioxybenzene; DTT, dithiothreitol; Man-6-P, D-mannose 6-phosphate; ManNAc, N-acetyl-Dmannosamine; ManNAc-6-P, N-acetyl-D-mannosamine 6-phosphate; MES, 2-morpholinoethanesulfonic acid; PEP, phosphoenolpyruvate; Sia, sialic acids; Neu5Ac, N-acetylneuraminic acid; Neu5Acyl, N-acylneuraminic acid; HPLC, high performance liquid chromatography; MALDI-TOF, matrix-assisted laser desorption ionization-time-of-flight.
D-glycero-D-galacto-nononic acid) is a distinct member of the sialic acids that shares many features in common with Nacylneuraminic acids (Neu5Acyl), including variations in the ␣-ketosidic linkages to the penultimate sugar residues and their occurrence in vertebrate glycoproteins (1-20), glycosphingolipids (5, (21) (22) (23) , and bacterial capsular polysaccharides (24) . The enzymes involved in KDN metabolism, including CMP-KDN synthetase (25) , KDN-transferase (26 -28) , and KDN residue-cleaving sialidases (29 -31) , have been identified and partially characterized, and their similarity and dissimilarity to the metabolism of Neu5Acyl residues have been described. In marked contrast, nothing is known concerning how the KDN monosaccharide is synthesized.
Two pathways are possible for synthesis of the KDN monomer. First, it could be formed directly from Neu5Ac by deacylation and deamination. Alternatively, it could arise by de novo synthesis via enzymes different from those required for synthesis of Neu5Ac. However, no evidence for the direct conversion of Neu5Ac to KDN has been obtained in any tissue homogenates examined to date. Thus, de novo synthesis by a separate pathway appears to be plausible by analogy with synthesis of other ulosonic acids. For example, 3-deoxy-D-arabino-heptulosonic acid 7-phosphate, a biosynthetic precursor of aromatic amino acids (32), 3-deoxy-D-manno-octulosonic acid, a constituent of bacterial lipopolysaccharides (33, 34) and Neu5Ac (35) are synthesized through a series of similar reactions involving a condensation of phosphoenolpyruvate (PEP) and the relevant sugar phosphates, either erythrose 4-phosphate for 3-deoxy-D-arabino-heptulosonic acid 7-phosphate, arabinose 5-phosphate for 3-deoxy-D-manno-octulosonic acid 8-phosphate, or N-acetylmannosamine 6-phosphate (ManNAc-6-P) for Neu5Ac 9-phosphate. Accordingly, the de novo biosynthesis of KDN is hypothesized to involve the condensation of PEP and mannose 6-phosphate (Man-6-P), giving rise to KDN 9-phosphate (KDN-9-P). Two additional reactions, the 6-O-phosphorylation of mannose (Man) and the dephosphorylation of KDN-9-P would presumably be required for KDN synthesis if Man and PEP were the intracellular substrates. It is conceivable, however, that these two reactions could be catalyzed by intracellular hexokinases and phosphatases, two ubiquitously occurring enzymes known to have broad substrate specificities (36, 37) . Thus, the purpose of this study was to elucidate the biosynthesis of the KDN monomer in rainbow trout ovaries and testis, tissues rich in expressing KDN-containing glycoconjugates (6 -8, 21-23) . Our initial studies have led to the discovery of a KDN-9-P synthetase, an activity that condenses Man-6-P and PEP in cytosolic fractions from both tissues. This activity was purified more than 50-fold from testis. Substrate competition experiments were used to show that the KDN-9-P synthetase activity was distinct from Neu5Ac-9-P synthetase, an activity responsible for condensing ManNAc-6-P and PEP.
EXPERIMENTAL PROCEDURES

Materials
[1- 14 C]Man (2.07 GBq/mmol) was purchased from American Radiolabeled Chemicals, Inc. 1,2-Diamino-4,5-methylenedioxybenzene (DMB), CMP-Neu5Ac, ATP, hexokinase (bakers' yeast), and N-acetylneuraminic acid aldolase from Escherichia coli were purchased from Wako Pure Chemicals (Japan). Sodium phosphoenolpyruvate, alkaline phosphatase from calf intestine, and Man-6-P were purchased from Sigma. Mannosamine hydrochloride was purchased from Nacalai Tesque (Japan). CMP-KDN and KDN were prepared as described previously (25, 28) . Rainbow trout ovaries, testes, and liver were collected a month before ovulation or spermiation.
Quantitation of Free, Lipid-bound, and Protein-bound Sialic Acids (Sia) in Rainbow Trout Ovary and Testis
All procedures were carried out at 4°C unless otherwise stated. Ovaries and testes (2 g each) were homogenized separately in 2 ml of 20 mM Tris-HCl buffer, pH 8.0, containing 0.1 M NaCl using a Polytron homogenizer (Kinematica, Switzerland). One ml of each homogenate was mixed with 4 ml of water and centrifuged at 100,000 ϫ g for 60 min. The supernatants were collected and designated the "cytosolic fraction." The precipitates were extracted serially with chloroform:methanol, 2:1 (v/v) and 1:2 (v/v), as described previously (21) . The extract and the resultant precipitate were designated as the "lipid fraction" and the "protein fraction," respectively. The lipid and protein fractions were each resuspended in 0.1 M trifluoroacetic acid and heated at 80°C for 30 min. After removal of any particulate material by brief centrifugation, the hydrolysates (designated as the lipid-and protein-bound Sia fractions, respectively) were derivatized with DMB. The cytosolic fractions were ultrafiltered through Microcon 10 (Amicon) to remove high molecular weight materials (M r Ͼ 10,000), and the filtrates (designated the "free Sia fraction") were derivatized with DMB. 2 The DMB derivatization of Sia and their analysis on the reverse phase HPLC (the DMB fluorometric HPLC method) were carried out as described previously (5) . In brief, the sample (20 l) in 40 mM trifluoroacetic acid was mixed with 20 l of 7 mM DMB in 5 mM trifluoroacetic acid, 1 M 2-mercaptoethanol, and 18 mM sodium hydrosulfite and incubated at 50°C for 2 h. Ten-l portions of the reaction mixture were applied to a TSK gel ODS-120T (4.6 ϫ 250 mm) column and eluted with acetonitrile:methanol:water (6:4:90, v/v/v), on a JASCO LC-900 HPLC system equipped with a JASCO FP-920 fluorescence detector (excitation, 373 nm; emission, 448 nm) operating isocratically at 1.0 ml/min at a column temperature of 26°C. DMB derivatives of KDN and Neu5Ac were well separated by HPLC and quantitatively determined in the pmol-nmol range.
Quantitative Determination of Man, ManNAc, and GlcNAc in the Cytosol of Trout Ovary and Testis
The free Sia fractions described above were analyzed. This fraction (derived from 10 mg of tissue) was subjected to pyridylamination (40) using GlycoTAG (Takara, Japan) according to instructions provided by the manufacturer. The pyridylaminated sugars were separated by a HPLC on PALPAK Type A column (4.6 ϫ 150 mm; Takara, Japan) and quantitated with an integrator connected to a spectrofluorometer (821-FP, JASCO, Japan) (excitation, 310 nm; emission, 380 nm). The column was eluted with 0.7 M potassium borate, pH 9.0:acetonitrile (9:1, v/v) at 65°C at 0.4 ml/min for 200 min.
Synthesis of [ 14 C]Man-6-P and a Reference Standard of [ 14 Preparative Synthesis of KDN-9-P and ManNAc-6-P
A large scale preparation of KDN-9-P was synthesized by incubating Man-6-P (5 mol) and sodium pyruvate (25 mol) with 1 unit of Nacetylneuraminic acid aldolase in 250 l of 25 mM phosphate buffer, pH 7.2, containing 0.01% NaN 3 at 37°C for 144 h. The reaction mixture was ultrafiltered through Microcon 10, and the filtrate was applied to a Mono-Q HR 5/5 column connected to an HPLC system (Irica, Japan). The column was eluted with a linear NaCl gradient (0 -0.25 M) in 10 mM monoethanolamine-HCl, pH 8.5, at a flow rate of 1 ml/min. Fractions positive for thiobarbituric acid method (41) , eluting around 130 mM NaCl, were collected and desalted by chromatography on a Sephadex G-10 column (1.0 ϫ 40 cm). The yield was about 10%. ManNAc-6-P was synthesized as described previously by Jourdian and Roseman (42) . From 0.1 mmol of mannosamine hydrochloride, 0.03 mmol of Man NAc-6-P was prepared through phosphorylation by hexokinase using 0.1 mmol of ATP and the subsequent acetylation.
Detection of Different Enzyme Activities in the Cytosolic Fractions of Trout Ovary and Testis
Three g of trout ovaries and testes were separately homogenized in 3 ml of homogenization buffer (50 mM MES, pH 7.0, containing 100 mM NaCl, 1 mM DTT, and 2 g/ml each of aprotinin, leupeptin, and pepstatin A) in a Polytron homogenizer and centrifuged at 100,000 ϫ g for 60 min. The resulting supernatant was used as the cytosolic fraction. For the KDN-9-P synthetase assay, 4 l of the substrate mixture containing 40 nmol each of PEP and Man-6-P and 2 nmol of sodium vanadate (a phosphatase inhibitor) were added to 16 l of the cytosolic fractions and incubated at 25°C for 24 h. Each incubation mixture received 5 l of alkaline phosphatase (30 units of enzyme in 2 mol of glycine buffer, pH 10.0, containing 250 nmol of MgCl 2 ), further incubated at 37°C for 1 h to dephosphorylate the reaction products, and analyzed for KDN by the DMB fluorometric HPLC method (see above). For the assay for hexokinase activity, 4 l of substrate containing 40 nmol of [ 14 C]Man (150 Bq/nmol), 100 nmol of ATP, 200 nmol of MgCl 2 , and 10 nmol of sodium vanadate were added to 16 l of the cytosolic fraction and incubated at 25°C for 24 h. The reaction mixture was analyzed for [
14 C]Man-6-P by using a cellulose TLC as described under "Quantitative Assay for KDN-9-P Synthetase and Neu5Ac-9-P Synthetase Activities." For the phosphatase assay, 4 l of KDN-9-P (20 nmol) were mixed with 16 l of the cytosolic fraction and incubated at 25°C for 24 h. The reaction mixtures were analyzed for KDN by the DMB fluorometric HPLC method (see above).
Purification of KDN-9-P Synthetase from Rainbow Trout Testis
All procedures were carried out at 4°C. Five g of mature rainbow trout testes that had been frozen immediately after collection and stored at Ϫ80°C were thawed, minced, and homogenized in a Polytron homogenizer in 20 ml of homogenization buffer (50 mM MES, pH 7.0, containing 1 mM DTT, 10% glycerol, and 1 g/ml each aprotinin, leupeptin, and pepstatin A). The homogenate was ultracentrifuged at 100,000 ϫ g for 60 min, and the supernatant was applied to a DEAEToyopearl 650M column (Tosoh, Japan; Cl Ϫ form, 2 ϫ 4 cm). The 2 Colorimetric quantitation of free Sia by the thiobarbituric acid method also gave the same results with a 5% error for the filtrates obtained after passage through YM10 (M r Ͼ 10,000) or YM5 (M r Ͼ 5,000). CMP-sialic acids were not detected in the filtrates from ovaries when examined on a Resourse Q anion-exchange HPLC. In rainbow trout ovary and testis, only free Sia was detected in the low M r region (Ͻ5,000) after Sephacryl S-200 chromatography of the cytosolic fractions. Thus, we conclude that Ͼ95% of the Sia in the filtrates existed as the free sugar acid. column was washed with 25 ml of 50 mM MES, pH 7.0, containing 1 mM DTT and 10% glycerol. The flow-through and wash fractions were combined and brought to 70% saturation with solid ammonium sulfate, stirred for 30 min, and centrifuged at 20,000 ϫ g for 30 min. Solid ammonium sulfate was added to the supernatant to 90% saturation, stirred for 30 min, and centrifuged again at 20,000 ϫ g for 30 min. The pellet, designated AS70-90, was dissolved in 20 mM Tris-HCl buffer, pH 9.0, containing 1 mM DTT and 10% glycerol and desalted on a minicolumn of Sephadex G-25 (PD-10, Amersham Pharmacia Biotech). The eluate was applied to a Poros HQ plastic column (Perseptive Biosystems) and eluted with 20 ml of a linear NaCl gradient (0 -0.25 M) in 20 mM Tris-HCl, pH 9.0, 1 mM DTT, and 10% glycerol. Fractions that contained the enzyme activity, which eluted between 125-160 mM NaCl, were collected.
Quantitative Assay for KDN-9-P Synthetase and Neu5Ac-9-P Synthetase Activities
Standard Quantitative Assay-For quantitative determination of the amount of enzyme activity, the following procedure was carried out. Enzyme fractions were first desalted, and the buffer was exchanged with 50 mM MES, pH 7.0, containing 1 g/ml each aprotinin, leupeptin, and pepstatin A by ultrafiltration using Microcon 10. To 20 l of the enzyme fraction 5 l of the substrate were added, either 25 mM Man-6-P (for KDN-9-P synthetase) or 5 mM ManNAc-6-P (for Neu5Ac-9-P synthetase). Each substrate also contained 25 mM PEP and 10 mM MnCl 2 . After incubation at 25°C for 20 or 30 min, the mixture was boiled for 3 min. Five l of alkaline phosphatase (30 units) in 0.5 M glycine-NaOH buffer, pH 10.0, and 60 mM MgCl 2 were added and incubated at 37°C for 1 h. With this incubation, quantitative dephosphorylation was attained. Trifluoroacetic acid was added, and the final concentration of trifluoroacetic acid and sample volume was adjusted to 40 mM and 100 l, respectively. The sample was ultrafiltered through Microcon 10, and the filtrate was analyzed for the amount of KDN and Neu5Ac by the DMB fluorometric HPLC analysis, as described above. One unit of enzyme activity is defined as the amount of enzyme required to synthesize 1 nmol of KDN-9-P or Neu5Ac-9-P/h at 25°C.
Routine Assay-For monitoring the elution profile of the KDN-9-P synthetase activity in the column chromatography fractions, the assay was routinely carried out as follows. Enzyme fractions were prepared as described above. To each enzyme fraction (5 l) was added [
14 C]Man-6-P (330 Bq, 160 pmol), PEP (20 nmol), MnCl 2 (10 nmol), and sodium vanadate (1 nmol). The final volume was adjusted to 10 l with water. After incubation at 25°C for 20 h, 2 l of alkaline phosphatase (1.5 to 7.5 units) in 1.2 mol of glycine-NaOH buffer, pH 10.0, containing 120 nmol of MgCl 2 were added, and the reaction was incubated at 37°C for 30 to 60 min. Three l of each sample were spotted onto plastic-backed cellulose TLC plate (Merck) and developed in 1-propanol, 1 M sodium acetate, pH 5.0, water (7:1:2, v/v/v) for 8 h (43) . When the effect of ionic strength was determined, the samples were spotted on Whatman No. 3MM paper and developed for 12 h in the same propanol:sodium acetate solvent noted above. Radioactivity was visualized and quantitatively determined using the Fujix BAS-2000 Imaging Analyzer (Fuji Photo Film, Japan).
Identification of the KDN-9-P Synthetase Reaction Product, KDN-9-P, by Matrix-assisted Laser Desorption Ionization-Time-of-flight (MALDI-TOF) Mass Spectrometry
Man-6-P and PEP (2.5 mol each) were incubated with the AS70-90 fraction (20 units) in 250 l of 50 mM MES, pH 7.0, containing 1 mM MnCl 2 , and 1 g/ml each aprotinin, leupeptin, and pepstatin A. After incubation at 25°C for 24 h, a flocculent precipitate that appeared was removed by centrifugation, and the supernatant was ultrafiltered through Microcon 10. The filtrate was applied to a Mono-Q HR 5/5 HPLC, and the thiobarbituric acid method-positive material was recovered and purified, as described under "Preparative Synthesis of KDN-9-P and ManNAc-6-P." This compound and its alkaline phosphatasetreated derivative were analyzed by the DMB fluorometric HPLC method. The alkaline phosphatase-treated derivative was prepared by the Mono-Q HPLC of the compound after incubation at 37°C for 3 h with the enzyme (10 units) in 30 l of 0.1 M glycine buffer, pH 10.0, containing 10 mM MgCl 2 . The purified product and its dephosphorylated derivative were also analyzed by MALDI-TOF mass spectrometry. The product (10 pmol) was mixed with 20 l of 2,5-dihydrobenzoic acid (2,5-DHB) in water, and 1 l of the sample was applied onto a gold target. After drying, the sample was analyzed on a Voyager Elite MALDI-TOF mass spectrometry system (PerSeptive Biosystems) with a nitrogen laser (337 nm) in negative ion mode at an accelerating potential of 12 kV.
Molecular Weight Estimation of KDN-9-P Synthetase
The apparent molecular weight of KDN-9-P synthetase was estimated by Sephacryl S-300 chromatography of the AS70-90 fraction (10 units). The column (1.4 ϫ 100 cm) was eluted with 50 mM HEPES buffer, pH 8.5, containing 100 mM NaCl, 1 mM DTT, 10% glycerol and calibrated using the gel filtration molecular weight standard kit (BioRad). Fractions (2.4 ml) were collected and assayed for KDN-9-P synthetase activity by the routine assay, as described above.
Characterization of the KDN-9-P Synthetase Activity
For determining the following properties of KDN-9-P synthetase, the enzyme activity was measured according to the routine assay (described above) using the AS70-90 enzyme fraction (0.3 unit), with varied conditions.
Effect of pH-The enzyme fraction was desalted by ultrafiltration using Microcon 10 and dissolved in 2 g/ml each aprotinin, leupeptin, and pepstatin A. This was mixed immediately with an equal volume of 100 mM Tris-HCl buffer, pH 7.2 to 9.0, or 100 mM MES, pH 5.5-7.0. The ionic strength of each buffer was adjusted to 0.1 by the addition of NaCl.
Effect of Ionic Strength-To determine the effect of the ionic strength on KDN-9-P synthetase activity, the concentration of NaCl in the different incubation mixtures was varied from 0 to 1.0 M.
Effect of Divalent Cations-Divalent cations were depleted from the enzyme fraction by incubation on ice for 60 min with 5 mM EDTA in 100 mM MES, pH 7.0, containing 1 g/ml each aprotinin, leupeptin, and pepstatin A. The mixture was ultrafiltered to remove EDTA and resuspended in the above buffer devoid of EDTA. Enzyme activity assays were carried out after addition of the following salts (1 mM) and preincubation for 30 
Determination of Kinetic Parameters and Substrate Competition Experiments
Kinetic Parameters-Twenty l of the AS70-90 enzyme fraction (1.1 unit), dissolved in 50 mM MES buffer, pH 7.0, containing 1 g/ml each aprotinin, leupeptin, and pepstatin A were mixed with 5 l of substrate containing 50 nmol of MnCl 2 , 125 nmol of PEP, and 25 to 125 nmol of Man-6-P or 2.5 to 50 nmol of ManNAc-6-P. After incubation at 25°C for 20 min, the reaction was terminated by heating at 100°C for 3 min. Five l of alkaline phosphatase (30 units) in 2.4 mol of glycine buffer, pH 10.0, containing 300 nmol of MgCl 2 were then added and incubated at 37°C for 1 h. Trifluoroacetic acid was added to terminate each reaction. The final concentration of trifluoroacetic acid and sample volume was adjusted to 40 mM and 100 l, respectively. The samples were ultrafiltered through Microcon 10, and the amount of KDN or Neu5Ac in the filtrates was quantitatively determined by the DMB fluorometric HPLC analysis, as described above. Kinetic parameters were determined by double-reciprocal Lineweaver-Burk plots (44) .
Substrate Competition Experiments-The assays were carried out as described above for determination of kinetic parameters, except that the incubation mixtures contained both Man-6-P and ManNAc-6-P. In the competition experiments, the concentration of one of the two sugar phosphates was held constant, whereas that of the other was varied (Man-6-P, 5 mM, and ManNAc-6-P, 0.1-0.5 mM or ManNAc-6-P, 1 mM, and Man-6-P, 1-5 mM).
RESULTS
Quantitative Determination of Free and Lipid-and Proteinbound KDN, Neu5Ac, and Neu5Gc in Trout Ovary and Testis-
The quantities of free and lipid-and protein-bound Sia in the ovaries or testes a month before ovulation or spermiation, when active synthesis of KDN-containing glycoconjugates occurs, are shown in Table I . The total amount of free and lipid-and protein-bound KDN, Neu5Ac, and Neu5Gc/g of tissue in ovary was 19-fold greater than that of testis (5,000 nmol versus 262 nmol). However, the total amount of KDN/g of ovary tissue was about one-third that of testis (60.5 nmol versus 161 nmol). These results suggest that although the overall metabolism of the Sia is more active in ovary 3 than in testis, KDN metabolism is considerably more active in testis. The molar ratios of free KDN:free Neu5Acyl (Neu5Ac ϩ Neu5Gc) were similar to those of bound Sia (1:88 versus 1:73 for ovary; 1:0.66 versus 1:0.57 for testis). The cytosolic concentrations of free KDN and Neu5Acyl are suggested to mirror the overall expression of bound KDN and Neu5Acyl residues on glycoconjugates in both trout ovary and testis.
Quantitative Determination of Sugar Precursors Required for KDN and Neu5Ac Synthesis in Rainbow Trout
Ovary and Testis-To assess the availability of metabolic sugar precursors required for KDN and Neu5Ac synthesis in rainbow trout ovary and testis, the level of free Man (precursor for KDN) and ManNAc (precursor for Neu5Ac) were quantitatively determined. The level of ManNAc in ovary was about 10-fold higher than Man (716 versus 76.4 nmol/g of tissue), whereas comparable levels of the two precursors were present in testis (36 versus 42 nmol/g of tissue). These results suggest that concentrations of the precursors, free Man and ManNAc, were reflected in the expression of free KDN and Neu5Acyl, respectively, in both trout ovary and testis (see above). No significant change in the amount of the free sugars was observed before and after treatment with alkaline phosphatase, indicating that the pool size of the free phosphorylated sugars was relatively small.
Identification of Enzyme Activities Required for KDN Synthesis in the Cytosol of Trout Ovary and Testis-Incubation of
homogenates or cytosolic fractions prepared from trout ovaries and testes with Neu5Ac and CMP-Neu5Ac did not result in the synthesis of KDN. 4 In contrast, incubation with Man-6-P and PEP resulted in a marked increase in the amount of KDN formed. These findings indicated that the cytosol contained a KDN-9-P synthetase activity. High levels of activities of hexokinase and phosphatase, both presumed to be involved in the de novo synthesis of KDN, were also present in the cytosolic fraction (data not shown). On the basis of these results, we conclude that KDN is synthesized by the condensation of Man-6-P and PEP and is not derived from Neu5Ac or CMP-Neu5Ac.
Purification of KDN-9-P Synthetase from Trout Testis-KDN-9-P synthetase was purified about 50-fold from rainbow trout testis, as summarized in Table II . After purification on a Poros HQ column, the enzyme fraction contained several proteins when analyzed by SDS-polyacrylamide gel electrophoresis and silver staining (data not shown). The 50-fold-purified KDN-9-P synthetase was unstable, preventing further purification of this enzyme activity. Accordingly, the enzyme was characterized using the ammonium sulfate-precipitated fraction, AS70-90. The AS70-90 was devoid of phosphatase activity that converted Man-6-P and KDN-9-P to Man and KDN, respectively. This fraction was stable for at least 1 month when stored at Ϫ80°C.
Identification of KDN-9-P as the Product of KDN-9-P Synthetase-Man-6-P
and PEP were incubated with the KDN-9-P synthetase AS70-90 fraction, and the product was analyzed on the DMB fluorometric HPLC (Fig. 1) . The DMB derivative of the reaction product and its phosphatase-treated derivative had the same retention times as the DMB derivative of authentic KDN-9-P (2.26 min) and KDN (8.56 min), respectively. The reaction product and its phosphatase-treated derivative were also analyzed by MALDI-TOF mass spectrometry. The molecular ions, (M-H) Ϫ , and their Na ϩ adducts, (M ϩ Na Ϫ 2H) Ϫ , were observed at m/z 346.5 and 368.7, respectively, for the presumed KDN-9-P product and at m/z 266.8 and 288.2, respectively, for the phosphatase-treated product. Thus, these results are consistent with the identification of the product as KDN-9-P.
Characterization of KDN-9-P Synthetase Activity in Rainbow Trout Testis-The optimum pH for KDN-9-P synthetase activity was between pH 7 and 8. The enzyme was active in the absence of exogenously added divalent cations but lost all activity when incubated before assay with 5 mM EDTA. The lost enzyme activity was restored to 2.4 -3 times higher levels of the original one by the addition of 1 mM MnCl 2 , CoCl 2 , or NiCl 2 and to one-third the original activity by 1 mM MgCl 2 . The other cations (Ca 2ϩ , Fe 2ϩ , Cu 2ϩ , and Zn 2ϩ ) did not restore enzyme activity. The enzyme activity was significantly inhibited in a concentration-dependent manner by NaCl. The activity was reduced by about 50% in the presence of 150 mM NaCl compared with the activity without added NaCl.
The apparent molecular weight of KDN-9-P synthetase was estimated to be about 80,000 by Sephacryl S-300 gel filtration chromatography. KDN-9-P synthetase had an obligatory requirement for Man-6-P and PEP, as determined by the standard quantitative assay method, as described under "Experimental Procedures." Man could not replace Man-6-P, nor could pyruvate replace PEP in the condensation reaction. No inhibition of the KDN-9-P synthetase activity was observed upon 
TABLE II Summary of the purification of rainbow trout testis
KDN-9-P synthetase The enzyme activity was estimated by the standard quantitative assay as described under "Experimental Procedures." One unit of enzyme activity is defined as the amount of enzyme required to synthesize 1 nmol of KDN-9-P/h at 25°C. The amount of protein was estimated by the bicinchoninic acid method (BCA, Pierce) using bovine serum albumin as standard.
Step a Supernatant (Sup) of the tissue homogenate after ultracentrifugation (Ucfg) at 100,000 ϫ g for 60 min.
b The error in the quantitation of the products by the DMB fluorometric method was empirically determined to be Ͻ5%.
c Combined flow-through and wash fractions after DEAE-Toyopearl column chromatography.
d Proteins precipitated by ammonium sulfate at 70 -90% saturation. e Activity eluting between 125-160 mM NaCl from Poros HQ column.
incubation of Man-6-P and PEP with either KDN (up to 1 mM), Neu5Ac (up to 1 mM), CMP-KDN (up to 0.5 mM), or CMPNeu5Ac (up to 0.5 mM).
Kinetic Properties of KDN-9-P Synthetase in Rainbow Trout
Testis-Synthesis of KDN-9-P from Man-6-P and PEP was found to increase linearly with the amount of enzyme, up to 2.2 units in 25 l of incubation mixtures. The kinetics of KDN-9-P formation was also shown to increase linearly with time for up to at least 8 h. At 5 mM Man-6-P, KDN-9-P synthesis increased as the concentration of PEP increased and approached saturation at 5 mM. Therefore, the kinetic constants for the enzyme were determined by varying the concentrations of Man-6-P in the presence of 5 mM PEP after incubation with 1.1 units of enzyme for 20 min in 25-l incubation mixtures. MichaelisMenten and Lineweaver-Burk plots for the synthesis of KDN-9-P are shown in Fig. 2, A and B . The kinetic constants for Man-6-P were K m , 3.66 mM, and V max , 0.201 mM/h. The AS70-90 enzyme fraction contained both KDN-9-P synthetase and Neu5Ac-9-P synthetase activities. These two activities could be differentiated, however, based on their substrate specificities and kinetic constants. Similar to the synthesis of KDN-9-P, synthesis of Neu5Ac-9-P from ManNAc-6-P and PEP was found to increase linearly with time for at least 4 h. At 5 mM ManNAc-6-P, synthesis of Neu5Ac-9-P also increased as the concentration of PEP increased and approached saturation at 5 mM. Therefore, the kinetic constants for Neu5Ac-9-P synthetase were determined by varying the concentration of ManNAc-6-P with 5 mM PEP using the same amount of enzyme described above. As shown in Fig. 2, C and D , the kinetic constants for ManNAc-6-P were determined to be K m , 0.245 mM, and V max , 0.301 mM/h. Separate Enzyme Activities Are Required for Synthesis of KDN-9-P and Neu5Ac-9-P-To determine if KDN-9-P synthetase and Neu5Ac-9-P synthetase activities in the AS70-90 fraction were due to the same active site on a single enzyme or to two different enzymes, the mixed substrate method of Dixon and Webb (45) was employed. As shown in Fig. 3 , the experimentally determined results significantly matched more closely the theoretical curve predicted for the two-enzyme rather than the one-enzyme theory, suggesting that the two enzyme activities are due to two separate catalytic sites. Slight deviation of the observed v t from the theoretical v t , calculated on the two-enzyme assumption, is interpreted to result from cross-inhibition of each enzyme by substrate competition (i.e. ManNAc-6-P for KDN-9-P synthetase and Man-6-P for Neu5Ac-9-P synthetase), as discussed more fully by Chevillard et al. (46) . Thus, each substrate may bind to the catalytic site on the respective enzyme but not serve as a substrate.
The Ratio of KDN-9-P to Neu5Ac-9-P Synthetase Activity Differ in Each Step During Purification-To confirm that the KDN-9-P and Neu5Ac-9-P synthetase activities resulted from separate enzymes, the ratio of both activities was determined in each fraction obtained during purification. If a single enzyme was responsible for synthesis of both KDN-9-P and Neu5Ac-9-P, then the ratio of the two activities would be predicted to remain unchanged during purification. In contrast, if more than one enzyme were responsible, then a differential change in the ratio of activities would be predicted. As shown in Table  III , the ratio of KDN-9-P to Neu5Ac-9-P synthetase activities differed significantly from each other during purification. The lower value (0.48) for the AS70-90 fraction compared with that for the DEAE-Toyopearl fraction (0.69) was likely due to the instability of KDN-9-P synthetase relative to Neu5Ac-9-P synthetase in the subsequent purification steps. Taken together with the results of the substrate competition experiments, these results strongly support our conclusion that synthesis of KDN-9-P is catalyzed by a specific KDN-9-P synthetase that is a different enzyme than the Neu5Ac-9-P synthetase, which catalyzes synthesis of Neu5Ac-9-P.
Rainbow Trout Liver Contains Higher Levels of Neu5Ac-9-P Synthetase than KDN-9-P Synthetase Activity-The enzyme fractions, Ucfg sup, DEAE-Toyopearl, and AS70-90, were prepared from the trout liver by the same procedures as those described for testis and assayed for KDN-9-P and Neu5Ac-9-P synthetase activities. As shown in Table III , the level of KDN-9-P synthetase was extremely low in all fractions compared with that of Neu5Ac-9-P synthetase activity. For example, in the AS70-90 fraction, the ratio of specific activities of KDN-9-P to Neu5Ac-9-P synthetase in liver was 0.031, whereas in testis it was 0.49. This difference in the level of expression of the two synthetase activities in testis and liver is in accord with our conclusion that the Neu5Ac-9-P and KDN-9-P synthetases are distinct enzymes and that the KDN-9-P synthetase is differentially enriched in trout testis compared with liver.
DISCUSSION
Synthesis of N-acylneuraminic acids in eukaryotes has been studied extensively for the last 40 years (35, (47) (48) (49) (50) (51) (52) (53) (54) , and reviewed in Refs. 55 and 56) . Recently, many of the enzymes involved in Neu5Ac metabolism have been purified (57) (58) (59) and cloned (60 -63) . These include GlcNAc 2-epimerase (60), UDP- HPLC elution profiles of DMB derivatives of the reaction product catalyzed by KDN-9-P synthetase. Man-6-P (10 mM) and PEP (10 mM) were incubated with the AS70-90 fraction (20 units) in 50 mM MES, pH 7.0, 1 mM MnCl 2 , 0.1 mM sodium vanadate, and 1 g/ml each protease inhibitors at 25°C for 24 h, and the product was purified and derivatized with DMB as described under "Experimental Procedures." The DMB derivative of KDN-9-P synthetase reaction product (A) and its alkaline phosphatase-treated derivative (B) were applied to a TSK-gel ODS-120T (4.6 ϫ 250 mm) column and eluted with acetonitrile/methanol/water (9: 7: 84, v/v/v) at 1.0 ml/min at a column temperature of 26°C. The elution profiles were monitored with a fluorescence detector (excitation, 373 nm; emission, 448 nm). The retention times of authentic KDN-9-P and KDN were 2.26 min and 8.56 min, respectively. The retention times for peaks 1 and 2 were the same as authentic KDN-9-P and KDN, respectively. (26, 28) , two key enzymes involved in the synthesis of KDNcontaining glycoconjugates, have been identified, there have been no published reports as to how the KDN monomer is synthesized. The significance of the new information provided in this study is that the pathway for KDN synthesis in rainbow trout ovary and testis has been shown to involve a condensation of PEP and Man-6-P as a key reaction: Man-6-P ϩ PEP 3 KDN-9-P ϩ P i . This reaction is catalyzed by the KDN-9-P synthetase. Hexokinase activity catalyzing formation of Man-6-P and phosphatase activity catalyzing dephosphorylation of KDN-9-P were also detected in the cytosol of trout ovary and testis. These activities may be due to the ubiquitous hexokinase and phosphatases known to be present in the cytosol of various cells (36, 37) , although we cannot exclude the possibility that there may be hexokinase and phosphatase activities specific for Man and KDN-9-P, respectively.
The cytosolic trout testis KDN-9-P synthetase had an obligatory requirement for Man-6-P and PEP and could not condense Man and PEP or pyruvate. Notably, however, the partially purified KDN-9-P synthetase activity used in this study could also condense ManNAc-6-P and PEP, suggesting that the enzyme fractions also contained Neu5Ac-9-P synthetase activity. These two activities were not separated from each other by column chromatography on Poros HQ or Cibacron Blue F3GA-agarose. However, the following three lines of evidence strongly support our conclusion that KDN-9-P synthetase and Neu5Ac-9-P synthetase are separate enzymes. First, the specific activity ratio of KDN-9-P to Neu5Ac-9-P synthetase activity varied among the fractions obtaining during the different steps in the purification procedure (Table III) . If these activities were on the same enzyme, the ratio would be expected to be constant in each fraction. Second, the results of substrate competition experiments using Man-6-P and ManNAc-6-P as competitors were consistent with the theoretical prediction that the two activities were distinct and thus likely represent two separate enzymes. Third, it was shown that the rainbow trout liver contained predominately Neu5Ac-9-P synthetase and little, if any, KDN-9-P synthetase activity. In contrast, trout testis con-FIG. 2. Kinetic analysis for the synthesis of KDN-9-P and Neu5Ac-9-P. PEP (5 mM) and varying concentrations of Man-6-P or ManNAc-6-P were incubated with the AS70-90 enzyme fraction (1.1 units) at 25°C for 20 min. The initial velocities were measured by quantitating the products by the DMB fluorometric HPLC method. Michaelis-Menten plots for the synthesis of KDN-9-P (A) and Neu5Ac-9-P (C) against varying concentrations of Man-6-P and ManNAc-6-P, respectively, and the Lineweaver-Burk plots for the synthesis of KDN-9-P (B) and Neu5Ac-9-P (D) are shown. tained both enzyme activities but was enriched in the level of KDN-9-P synthetase activity. Notably, these findings appear consistent with the fact that the levels of KDN in liver are significantly less than in testis, whereas Neu5Ac is abundant in both tissues (21) . These results also support our conclusion that KDN-9-P synthetase is actually distinct from Neu5Ac-9-P synthetase in trout testis. Our analyses do not allow us to determine unequivocally, however, if both activities reside on a single or separate polypeptide chains. To differentiate between these two possibilities, purification of either the KDN-9-P or Neu5Ac-9-P synthetase to homogeneity will be required.
The relative expression level of KDN-to Neu5Acyl-containing glycoconjugates in trout testis is relatively high (59.5 versus 34 nmol/g tissue; Table I ; Refs. [21] [22] [23] . This is consistent with the relatively higher level of free KDN to free Neu5Acyl (101 versus 66.6 nmol/g of tissue; Table I) and the somewhat higher level of Man to ManNAc (42.3 versus 36 nmol/g of tissue). This latter result is also consistent with our finding that in trout testis Man and ManNAc are the biosynthetic precursors for KDN and Neu5Ac, respectively. We found, however, a 3.5-fold higher level of Neu5Ac-9-P synthetase than that of KDN-9-P synthetase, based on the ratio of specific activities in the cytosolic Ucfg fraction (Table II) . Although this may appear to be inconsistent with the relatively lower abundance of Neu5Acyl than KDN residues in trout testis (Table I) , we believe this finding may simply reflect the reduced levels of ManNAc-6-P required for the Neu5Ac-9-P synthetase. Thus, the relatively lower level of expression of Neu5Acyl to KDN residues in trout testis appears to be positively correlated with attenuation of enzyme activities required for synthesis of ManNAc.
It is known that Man-6-P can be synthesized by at least two possible biosynthetic pathways in eukaryotic cells. In the first, Man-6-P is formed in the cytosol from fructose 6-phosphate by phosphomannoisomerase. Alternatively, Man can be phosphorylated by a 6-O-phosphokinase after transport into the cell via mannose-specific transporters (65, 66) . Most Man residues that are incorporated into the N-linked oligosaccharide chains in glycoproteins are derived from the latter pathway (65, 66) . Therefore, the substrate pool of Man-6-P could originate from intracellular free Man via direct phosphorylation or via phosphomannoisomerase. Our studies clearly show that Man-6-P can be synthesized in the cell once Man is provided. Interestingly, ManNAc-6-P is reported to be synthesized from UDPGlcNAc and ATP by a single bifunctional enzyme, UDP-GlcNAc 2-epimerase/ManNAc kinase (57) . This appears to be a distinctly different feature for the synthesis Neu5Ac compared with KDN, because an analogous pathway from UDP-Glc to Man-6-P via Man has not been reported.
Expression of KDN-containing glycoproteins and glycolipids in mammalian tissues has only recently been reported. These studies have shown that KDN residues are expressed in a tissue-, developmental-, tumor-, and protein-specific manner (5, 8, 19, 20) . Elucidation of the metabolic pathway for KDN expression in mammalian cells is difficult to study because of the small quantities of KDN present (5) . The present studies thus represent an important step in this endeavor because they describe the pathway for synthesis of the KDN monomer in trout testis, catalyzed by a KDN-9-P synthetase, a finding that has not been previously described. The difficulty in purifying the enzyme to homogeneity highlights the importance of the FIG. 3 . Separate synthetases are required for synthesis of KDN-9-P and Neu5Ac-9-P. Substrate competition experiments. Incubation mixtures containing the partially purified KDN-9-P and Neu5Ac-9-P synthetases (AS70-90 fraction, 1.1 units) were set up that contained fixed concentrations of either Man-6-P (A) or ManNAc-6-P (B) and varying concentrations of ManNAc-6-P (A) or Man-6-P (B), respectively. Incubation was carried out at 25°C for 20 min. The kinetic constants for Man-6-P and ManNAc-6-P were determined as described under "Experimental Procedures." The theoretical total velocities, v t , calculated assuming one enzyme (open circle) or two enzymes (open circle with cross) and the observed v t (closed circle) are shown. In both cases, the observed v t more closely approximates that expected for two enzyme activities rather than one.
TABLE III
Specific activities of KDN-9-P and Neu5Ac-9-P synthetases in rainbow trout testis and liver Each fraction was prepared in exactly the same way from both tissues. The KDN-9-P and Neu5Ac-9-P synthetase activities of each fraction containing the same protein concentration were estimated by the standard quantitative assay as described under "Experimental Procedures." One unit of enzyme activity is defined as the amount of enzyme required to synthesize 1 nmol of KDN-9-P or Neu5Ac-9-P/h at 25°C. 
Testis
Liver KDN-9-P synthetase Neu5Ac-9-P synthetase KDN-9-P/Neu5Ac-9-P KDN-9-P synthetase Neu5Ac-9-P synthetase KDN-9-P/Neu5Ac-9-P Table II. need to clone, overexpress, and purify the KDN-9-P synthetase activity from trout testis as one step in advancing our understanding of how expression of the KDN glycotope may be regulated (67) . Given that the levels of free KDN are 2.4-fold higher in fetal cord red blood cells compared with matched maternal red blood cells and is also elevated in ovarian cancer cells, the present study highlights the importance of future studies to elucidate the role that free KDN and KDN-glycoconjugates may play in normal development and malignancy.
